SWAT

Last updated on: 17.04.2025

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

SWAT is the acronym for Severity of Illness Assessment Tool or Severity Weighting Assessment Tool. SWAT is a severity assessment tool and is typically used to assess the complexity or severity of clinical situations, especially in tumor patients in oncology or palliative care.

General informationThis section has been translated automatically.

The SWAT tool is used to systematically evaluate clinical cases, e.g. as part of tumor boards or for interdisciplinary case discussions. It is used for prioritization, decision support and treatment planning.

Possible dimensions in SWAT (depending on version):

  • Disease burden / tumor stage
  • Symptom burden (e.g. pain, shortness of breath, fatigue)
  • Psychosocial burden
  • Need for therapy / need for intervention
  • Prognosis
  • Palliative care needs

Assessment: Each area is often assessed on a scale (e.g. 0-3 or 0-5). The sum or weighting points then result in an overall SWAT score, which can be used to classify cases as mild, moderate or highly complex, for example.

Application:

  • Tumor boards (for case selection and case sequence)
  • Palliative consultations
  • Clinical studies for patient selection
  • Resource planning

LiteratureThis section has been translated automatically.

  1. Stevens SR et al. (2002) Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT). Arch Dermatol 138:42-8

Last updated on: 17.04.2025